Milind Kamkolkar is the CDO of Cellarity, where the “D” is both Digital and Data. At Cellarity, digital is the operating model and data is a core value driver of the company. With this integrated approach, Milind is leading Cellarity’s diverse AI and Digital organization, which implements machine learning science on a digital biology landscape to explore new clinical hypotheses that can alter cell behaviors. His dream was to build a therapeutics company that integrated digital and data as a business-as-usual, interdisciplinary and non-hierarchical model. For the first time in the life sciences industry, this is happening at Cellarity.
Milind joined Cellarity from Sanofi where he was the first enterprise Chief Data Officer in the pharmaceutical industry. Milind’s focus was transforming Sanofi from a data-generation organization into a data-driven organization, to empower the lives of patients and enrich the value Sanofi delivered to customers. The approach was drawn from his tenure at Novartis where he was the Global Head of Data Science and AI in Digital Medicines.
Milind is an intrapreneur and entrepreneur with a career spanning big pharma, big and boutique consulting and numerous technology and software startup companies focused at the intersection of health, technology and data. His relentless commitment to excellence across the value chain of pharma has led to multi-billion-dollar impacts by blending digital insights and partnership approaches across industries to solve complex human health problems at scale.
Milind is a featured speaker (TEDx), Business Transformation Top 150 Leader and thought leader in digital health, AI and big data. Milind has served as a board advisor and mentor to numerous startups, founders and VC firms focused on entering the life science space through digital, data or AI. He has served as an Honorary Lecturer for Physician Entrepreneurship at BartsX, Faculty at Exponential Medicine and a Former Special Advisor to the UN Global Compact Sustainable Development Goals program.
Milind holds a B.Sc. from the University of Sydney and M.S. from Thomas Jefferson University.